We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.
By Katie Soisson, NHC Policy Associate The NHC’s Action Teams are an integral part of the organization’s policy-making process and serve as one of the
The National Health Council (NHC) appreciates the opportunity to provide comments on the Food and Drug Administration’s (FDA’s) draft guidance on Patient-Focused Drug Development: Collecting
Today, the NHC debuted its first online educational series, Increasing Patient-Community Capacity to Engage on Quality of Health Care. The series, comprised of six modules,
By: Marc Boutin, JD, Chief Executive Officer The National Health Council (NHC) acknowledges the complexity of the opioid crisis in the United States and commends
In today’s New York Times, Aaron Carrol writes about the use of comparative effectiveness research to ensure new drugs are safe and effective when compared
The National Health Council (NHC) has named Elisabeth Oehrlein, PhD, MS, as Senior Director, Research and Programs. In this newly created, leadership position, Dr. Oehrlein
By Marc Boutin, JD, NHC Chief Executive Officer Last week, the Centers for Medicare and Medicaid Services (CMS) issued a new policy touted as a
Today, FDA Commissioner, Scott Gottlieb, MD, spoke at our event, a dialogue on FDA’s first draft guidance on patient-focused drug development. Meeting participants engaged and
The National Health Council (NHC) is exploring how we communicate our work to members and to external audiences. For nearly 100 years, the NHC has